|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Systemic Lupus Erythematosus | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Lupus Erythematosus, Systemic | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Connective Tissue Diseases | |||||
| Immune System Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| belimumab | |||||
| Placebo | |||||
| 5 | Sponsors listed in this trial | ||||
| Human Genome Sciences | |||||
| GlaxoSmithKline | |||||